BofA downgraded Option Care Health (OPCH) to Neutral from Buy with a $29 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Alphabet, AMD report Q3 earnings beats: Morning Buzz
- Option Care Health sees ‘drastic,’ ‘rapid’ impact in early 2025 from biosimilars
- Option Care Health reports Q3 adjusted EPS 41c, consensus 31c
- Option Care Health sees FY24 revenue $4.9B-$4.95B, consensus $4.83B
- OPCH Upcoming Earnings Report: What to Expect?